Table 3.
Organ-specific tumor response (n = 140)
| Sites | CR | PR | SD | ORR | DCR | |||
|---|---|---|---|---|---|---|---|---|
| Liver (n = 129) | 9 | 7.0% | 16 | 12.4% | 40 | 31.0% | 19.4% | 50.4% |
| Thrombosis (n = 81) | 2 | 2.5% | 4 | 4.9% | 25 | 30.9% | 7.4% | 38.3% |
| Lung (n = 15) | 2 | 13.3% | 3 | 20.0% | 3 | 20.0% | 33.3% | 53.3% |
| Lymph node (n = 7) | 0 | 0.0% | 1 | 14.3% | 1 | 14.3% | 14.3% | 28.6% |
| Peritoneum (n = 5) | 1 | 20.0% | 1 | 20.0% | 0 | 0.0% | 40.0% | 40.0% |
| Bone (n = 5) | 0 | 0.0% | 0 | 0.0% | 1 | 20.0% | 0.0% | 20.0% |
| Adrenal gland (n = 4) | 0 | 0.0% | 2 | 50.0% | 0 | 0.0% | 50.0% | 50.0% |
CR complete response, PR partial response, SD stable disease, PD progressive disease, ORR objective response rate, DCR disease control rate